AIM • AGY • GB00B02LCQ05
Generating your data highlights...
N/A USD | # 2702 in GB
465.87k shares | 32.01k USD
6.33b
11.43% | 723.79m
Allergy Therapeutics (AIM: AGY). Last close 4.5 GBp; 52-week range 4 GBp to 12.1 GBp. ORTEX data as of 2026-10-19: short interest is 0% of free float, 0 days to cover and the average cost to borrow is 17.67%.